Recent Articles from GlobeNewswire

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 27, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company"), today announced that it has entered into an evaluation agreement with Manoira Corporation ("Manoira"), a specialty animal health company, to assess the potential of CDT's clinical-stage assets AZD1656, including certain proprietary cocrystal derivatives, and AZD5904 to enhance Manoira's forthcoming animal health products.

NeuroOne’s FDA 510(k)-Cleared OneRF Trigeminal Nerve Ablation System Offers Hope for Patients Suffering from Trigeminal Neuralgia

Third Quarter 2026 Financial Highlights

Award-winning certification exam prep platform introduces ‘Tutor’ to help adult learners retrieve the knowledge they already know, connect it to new concepts, and retain what they learn

400,000-square-foot site will support growing customer demand in the infrastructure vertical, including data centers and power utilities

NEW ORLEANS, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Humanitas Global Health, a mission-driven initiative applying explainable, traceable artificial intelligence and breakthrough science to reduce preventable suffering and expand access to better care worldwide, today announced its launch and an agreement licensing DeepDrug technologies from Louisiana State University for commercialization. Humanitas translates promising discoveries into practical tools that accelerate drug development, improve medication safety, and support more precise clinical decisions.

Second consecutive year on the ranking, reflecting sustained growth, financial strength, and stock performance

Vancouver, British Columbia, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB10; OTCQB:TEBAF) is pleased to announce that Terra North Resources Corp. (“Terra North”), in which Terra owns 35.1% equity, has received the final dataset from the previously announced airborne survey conducted over its flagship Charlot-Neely Lake claims located ca. 20 km north of Uranium City, Saskatchewan (see the Company's news release dated September 4th, 2026). Terra North holds an option to acquire 100% interest in the Project from Fulcrum Metals Canada Ltd. subject to satisfying certain earn-in requirements (see the Company's news release dated July 3rd, 2024).

Naples, Italy and Hamilton, Bermuda, Oct. 27, 2026 (GLOBE NEWSWIRE) -- The RoyaLand Company Ltd. (the “Company” or “RoyaLand”) (OTCQB: RLNDF), a Bermuda holding company focused on creating immersive, fantasy-based royalty-themed games and growing its Italian professional football club Savoia 1908 FC, today revealed more about Regalia Cards, a free to play mobile card game in which the noble houses of a royal court compete for honor across the card table. Built for iOS and Android, the game is targeting a Q4 2026 launch.

Thousands of amazing holiday finds for $5 and below, from viral squishies and Christmas tree trimmings to toys, stocking stuffers and more

SINGAPORE, Oct. 27, 2026 (GLOBE NEWSWIRE) -- HomesToLife Ltd (Nasdaq: HTLM) (“HomesToLife” or the “Company”), a Cayman Islands exempted company headquartered in Singapore with sales across Asia-Pacific, Europe and North America, today announced the results of an extraordinary general meeting (the “EGM”) held on October 27, 2026 at 10:00 A.M., Singapore Time (10 P.M. Eastern Time on Oct 26, 2026). The successful completion of the EGM represents a key milestone in the Company’s proposed secondary listing by way of an introduction of its ordinary shares on the Mainboard of the SGX-ST (the “Proposed Secondary Listing”).

NEW HAVEN, Conn., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Bexorg, Inc., a precision neurology company, built on an integrated AI and whole-human brain platform, today announced the appointment of Mikael Dolsten, M.D., Ph.D., as Chairman of its Board of Directors. Dr. Dolsten brings more than three decades of global leadership across research and development, including strategy and portfolio management, with experience spanning small-molecule medicines, biotherapeutics, gene therapies and vaccines. He succeeds Zvonimir Vrselja, M.D., Ph.D., Co-Founder and Chief Executive Officer, who has served as Chairman since the company’s founding and will continue as CEO and a member of the Board. The company also announced that Jon Faiz Kayyem, Ph.D., is retiring from the Board after serving as an independent director.

TEL AVIV, Israel, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that it has completed the acquisition of assets from BioXcel Therapeutics, Inc., including worldwide rights to BXCL501. BXCL501 is an investigational dexmedetomidine sublingual film under FDA review for at-home use in the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. If approved, BXCL501 would be the first FDA-approved treatment patients could use at home for this condition. The acquisition expands Teva’s innovative neuroscience pipeline with a late-stage asset with the potential to address a significant unmet patient need.

Portage, Michigan, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Jefferies Global Healthcare Conference on Tuesday, November 17, 2026, at the Waldorf Hilton and ME Hotel in London.

New leaders round out TrueCommerce’s executive bench as the company advances intelligent, connected supply chain operations

Co-founders to step down from executive roles and continue to serve on the Board of Directors

Across hundreds of studies and focus groups with 7,000+ legal professionals, lawyers describe the same friction: disconnected AI experiences, lost context, lack of verification, and time wasted formatting work 

WASHINGTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- The latest CapEx Finance Index (CFI), released today by the Equipment Leasing & Finance Association (ELFA), showed that equipment demand remained strong in September. New business volume was essentially unchanged from August, making September the third-strongest month in the survey's history, and the full-year forecast held steady at an all-time high. Financial conditions remained healthy, with the delinquency rate falling to its lowest level since April 2023. Additional Fed rate hikes and elevated economic uncertainty remain risks, but strong demand and healthy credit quality leave the industry well positioned heading into the final quarter of the year.

2026 Outlook Raised on Record Profitability; Millar Acquisition Advances Diversification

The agreement supports EyeLief® combination drug-device product development in anticipation of a future clinical program, with polymer supply also supporting OcuLief® and non-ocular applications

BERLIN, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Global energy technology leader Schneider Electric, industrial software leader AVEVA, full-stack AI cloud platform Nscale, and data center developer and operator Start Campus, today announced the successful pilot of an end-to-end digital twin developed using the NVIDIA Omniverse DSX Blueprint, part of NVIDIA DSX Sim.

With the Flatiron Institute and leading European research institutions, Pasqal used its 256-qubit processor to observe an unexpected slowdown in a 2D quantum magnet, in a regime that current theory and classical simulations cannot yet reliably predict.

  

WILMINGTON, Del., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Global Indemnity Group, LLC (NASDAQ:GBLI) (“GBLI”) announced today that it will release its third quarter 2026 earnings results before market open on Wednesday, November 4, 2026.

Following its recent offtake agreement and increased commercial demand, Emvolon raises Series A and non-dilutive federal and state grants to launch first commercial system and adds industry growth veteran to its board to accelerate project pipeline

Multiple Posters Highlight the Breadth of Company’s Novel Genetic Medicine and Cell Therapy Platforms

Dr. Arjona Ferreira currently serves as Head of Research and Development and Chief Medical Officer at Organon & Co. (NYSE: OGN)

Single-dose CLD-401 induced tumor regression and complete response in 80% of mice in EMT6 breast tumor model

Approval under the EU Clinical Trials Regulation builds on CAMP4’s recent clearances in the United Kingdom, Australia, and Argentina to initiate the Company’s global Phase 1/2 trial of CMP-002

VANCOUVER, Wash. and NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will be participating in the following upcoming investor conferences:

WILMINGTON, Del., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001, a novel once-daily oral anti-proliferative for Pulmonary Arterial Hypertension (“PAH”), today announced that the Company’s management will be participating in the following investor conferences during the month of November and December 2026.

Nes-Ziona, Israel, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the "Company"), a quality longevity company powered by a prediction markets treasury, today announced receipt of a delisting notification dated October 26, 2026 (the “Delisting Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (“Nasdaq”), stating that the closing bid price of the Company’s ordinary shares during the 30 consecutive business days prior to October 22, 2026 did not meet the $1.00 minimum bid price requirement in accordance with Nasdaq Listing Rule 5550(a)(2).  Because the Company effected a reverse share split within the preceding 12 months, the Company is not entitled to a 180-day period to regain compliance with the minimum bid price requirement.

BRIDGEWATER N.J., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 a.m. ET on Tuesday, November 10, 2026, to review third quarter 2026 financial results.

New experience introduces Lu, an AI-powered insurance guide that allows consumers to compare coverage through conversation and get real-time quotes they can act on

Quarterly Highlights:

Planning underway for registrational trial of WVE-006 (RNA editing) in AATD, with an interim analysis for potential accelerated approval based on AATD biomarkers

Private equity operations expert brings more than 20 years of experience helping investors and portfolio companies improve EBITDA, optimize operations and accelerate enterprise value creation

Shelton, CT, Oct. 27, 2026 (GLOBE NEWSWIRE) --

Jena, Germany, Oct. 27, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced its events calendar for November.

Company’s Executive Chairman and CEO to Speak on Cancer Therapeutics Spotlight Panel at BioFuture in NYC and Deliver Keynote Address at Global Biotechnology Summit in Abu Dhabi

HOLLISTON, Mass., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2026, before the market opens on November 10, 2026, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. 

Latest DSP integration expands buyer access to OptimizeRx point of care inventory through existing programmatic workflows

SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva or the Company), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating autoimmune diseases, today announced that it will discontinue further development of AlloNK® (AB-101), its non-genetically modified, allogeneic NK cell therapy candidate being evaluated in combination with rituximab in rheumatoid arthritis (RA) and other B-cell-driven autoimmune diseases. The decision follows the Company’s review of the overall risk-benefit in the context of updated clinical data, including longer-term follow-up, and recent Grade 5 safety events. The Company also announced that it is implementing a reduction in workforce and evaluating strategic alternatives to maximize stockholder value that may include a merger, business combination, sale or licensing of assets, or dissolution and liquidation.

HOUSTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) today announced that the High Court of Ireland has approved the previously announced scheme of arrangement through which the Company intends to change its legal domicile from Ireland to Delaware.

SALT LAKE CITY, UTAH, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Lumion is outlining its approach to business automation through AI agents designed to manage customer inquiries, support automated follow-up, and reconnect with prospective customers. The company's platform brings together AI-powered communication, workflow automation, and a unified inbox to help organizations coordinate customer interactions across calls, text messages, and website inquiries.

TORONTO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Flow Capital Corp. (“Flow Capital” or the “Company”) (CSE: FW), a leading provider of flexible growth capital and alternative debt solutions for high-growth companies, is pleased to announce that its common shares will begin trading on the Canadian Securities Exchange (the “CSE”) under the new ticker symbol “FLOW”, effective at market open on October 29, 2026.

Durable Complete Response Achieved with Single Administration of Iopofosine I 131 

White River Strategy launches its Social Sector AI Readiness Report, Highlighting the Need to Move Beyond Individual AI Usage and Embrace Organizational AI Integration

VANCOUVER, British Columbia, Oct. 27, 2026 (GLOBE NEWSWIRE) -- RecycLiCo Battery Materials Inc. (“RecycLiCo”) (TSX.V: AMY | OTCQB: AMYZF | FSE: ID4), a critical mineral refining and lithium-ion battery upcycling company, and Alaska Energy Metals Corp. (“AEMC”) (TSX.V: AEMC | OTCQB: AKEMF | FRA: V7F) are pleased to announce the commencement of testing of metal concentrate samples derived from drill core from the 2023-2024 exploration campaigns at the polymetallic Eureka deposit, located at AEMC’s Nikolai Nickel Project in Alaska. The work is being done at RecycLiCo’s laboratory in Delta, BC, in accordance with a protocol prepared by RecycLiCo and approved by AEMC. Testing is in furtherance of the previously announced memorandum of understanding (“MOU”) between AEMC and RecycLiCo’s U.S. subsidiary to assess the ways in which RecycLiCo’s hydrometallurgical processing technology could be used in refining the output from the Eureka deposit, which contains seven U.S. Government-designated Critical Minerals, including nickel, cobalt, copper, chromium, platinum, palladium, and gold (along with the non-critical mainstay metal iron). Recently reported locked cycle flotation results have proven strong recoveries of metals reporting to a bulk nickel-copper concentrate. AEMC is exploring multiple avenues for hydrometallurgical testing to determine the optimum extraction technique to achieve the highest value from downstream processing of the bulk concentrate.

MammoLink joins Mammogen’s KATELYN-ERIN trial, expanding community access to a prospective study evaluating blood-based RNA biology for breast cancer detection

Global regulatory clearances in the U.S. and Australia support initiation of a Phase 1b/2a study in relapsing and refractory ITP and wAIHA

Reliable, high-performance connectivity will support time-critical transport and monitoring of donor organs for transplants aboard 22 Embraer Phenom 300E aircraft

DURHAM, N.C., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that CEO Anshul Thakral, CFO Jason Knoblauch, and SVP of Investor Relations Tracy Krumme will participate in the following conference:

Located in the Johor-Singapore Special Economic Zone, the Medini site expands GXO’s presence in Asia Pacific and provides enhanced flexibility across regional supply chains

(All dollar amounts are expressed in Canadian dollars, unless stated otherwise)

PHILADELPHIA, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, will host a conference call and live audio webcast on Thursday, November 5, 2026 at 8:30 a.m. ET to report its third quarter 2026 financial results and corporate updates.

BOSTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Factorial Energy Inc. (“Factorial”) (Nasdaq: FAC), a global leader in solid-state battery technology, today announced it will release financial results for the third quarter 2026 after the market closes on Tuesday, November 10, 2026. Management will host a webcast and conference call that same day at 4:30 PM ET to review results.

JERSEY, Channel Islands, 27th October 2026 - CoinShares PLC (Nasdaq: CSHR) (“CoinShares” or the “Company”) today announced that its Board of Directors has approved a program to repurchase up to $40 million of the Company’s ordinary shares, pursuant to the shareholder authority granted at the 15th of September 2026 Extraordinary General Meeting. The program will remain authorised until the Company’s next Annual General Meeting, expected in Q2 2027.

BEIJING, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Luckin Coffee Inc. (“Luckin Coffee” or the “Company”) (OTC: LKNCY) will release its third quarter 2026 financial results before the U.S. market opens on Tuesday, November 3, 2026.

NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Marex Group Limited (‘Marex’ or the ‘Group’, NASDAQ: MRX), the diversified global financial services platform, today announces that Kory Sorenson will join the Group Board with effect from 2 November 2026.

OREM, Utah, Oct. 27, 2026 (GLOBE NEWSWIRE) -- SunPower Inc. (“SunPower,” or the “Company”)(Nasdaq SPWR), a solar technology, services, and installation company, today announced an expansion in Texas through the acquisition of prime project assets from Houston installer Greenlight Solar, as well as a second strategic partnership with Fort Worth financier SOLRITE Energy to expand its residential solar and storage offerings and accelerate its Virtual Power Plant (VPP) business in which residential and commercial batteries can sell power.

SAN DIEGO and SUZHOU, China, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced that senior management will participate in a fireside chat and one-on-one meetings at the Guggenheim Securities 3rd Annual Healthcare Innovation Conference being held November 9-11, 2026 in Boston, MA.

Hong Kong, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Magic Empire Global Limited (“MEGL” or the “Company”) today announced that on October 22, 2026, it entered into a letter of intent (the “Letter of Intent”) with Singapore-based commodity trading enterprise SIN HOPEWAY PTE. LTD., for a five year strategic cooperation to develop an international timber import and export supply chain business, commencing from the date of the Letter of Intent. During the five-year cooperation period, the Company, having completed its strategic industrial upgrade, shall supply SIN HOPEWAY PTE. LTD. with raw timber materials. The cumulative target trade volume between the parties shall be US$500 million.

WILMINGTON, Del., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its fourth-quarter fiscal 2026 earnings release at approximately 5 p.m. ET on Tuesday, November 3, 2026. The company’s live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Wednesday, November 4.  Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com.

GOLETA, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) --  Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum, announced today that it will participate in the following upcoming investor conferences:

In the 40 mg Cohort, Two Patients Achieved 15 Hours of Controlled Fasting, Improvements in Glucose Control and No Longer Required Starch Supplementation Following Treatment 

DURHAM, N.C., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the third quarter of fiscal year 2026 after the market closes on Monday, November 2, 2026. The Company’s management will host a conference call at 4:30 p.m. Eastern Time that same day to discuss the results and provide a business update.

NEW HAVEN, Conn., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will review third quarter 2026 financial results and provide a corporate update during a live webcast on Tuesday, November 3, 2026 at 8:00 a.m. ET.

WARREN, N.J., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a biopharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it will report financial results for the third quarter ended September 30, 2026, and provide an update on recent developments in its business after market close on Tuesday, November 3, 2026.

Direct-to-consumer meat brand gathers supporters calling on USDA to make ‘No Antibiotics Ever’ chicken available in cafeterias across the country

ATLANTA, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Herschel Parts, a global manufacturer and distributor of aftermarket agricultural replacement parts to businesses and consumers, is using the Descartes Pacejet™ multicarrier shipping solution integrated with its enterprise resource planning (ERP) system. Herschel is processing 98% of its shipments through one workflow spanning parcel and less-than-truckload (LTL) carriers. By consolidating shipping workflows and carrier rating, Herschel has eliminated approximately 10 hours per week of manual data entry, gained immediate shipment visibility and identified carrier options that can be 5% to 10% less expensive for individual shipments.

HOUSTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- DNOW Inc. (NYSE:DNOW) has scheduled a conference call to discuss the results for the third quarter of 2026 on Thursday, November 5, 2026 at 8:00 am (US Central Time). Financial results for the third quarter ending September 30, 2026 are expected to be released that morning before the market opens.

The Bank of Tianjin Tianjin Marathon 2026

Third Quarter 2026 Financial Highlights

FDA indicates proposed double-blind Phase 2/3 design could be considered adequate and well controlled as Merakris prepares its first commercial-pilot GMP drug lot for a potentially pivotal trial.